prdx2 a 2 mouse monoclonal (Santa Cruz Biotechnology)
Structured Review
Prdx2 A 2 Mouse Monoclonal, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 19 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prdx2/PRX+II+Antibody/pm41932903-352-162-166
Average 93 stars, based on 19 article reviews
Images
Related Articles
Gentle:Article Title: Differential expression of peroxiredoxin 3 in laryngeal squamous cell carcinoma Article Snippet: .. Proteins were separated by 12% gel SDS-PAGE, transferred to polyvinylidene difluoride membranes, blocked with 5% (w/v) skim milk for 1 h, and co-incubated for 1 h with the primary antibody of PRDX1 (ab41906, Abcam, Cambridge, UK), shRNA:Article Title: Peroxiredoxin 2 contributes to the malignant phenotype of glioblastoma cells. Article Snippet: Glioblastoma (GBM) is the most malignant primary brain tumor.. To adapt to intrinsic oxidative stress, GBM cells upregulate antioxidant systems.. Out of six peroxiredoxins (PRDX) involved in protecting cells from oxidative stress, PRDX1 and PRDX4 are proteins that have been attributed with GBM-promoting properties. other:Article Title: BMP signaling-driven osteogenesis is critically dependent on Prdx-1 expression-mediated maintenance of chondrocyte prehypetrophy. Article Snippet: During endochondral ossification, cartilage template is eventually replaced by bone.. This process involves several well characterised, stereotypic, molecular and cellular changes in the cartilage primordia.. These steps involve transition from resting to proliferative and then prehypertrophic to finally hypertrophic cartilage. Article Title: Quercetin induces the expression of peroxiredoxins 3 and 5 via the Nrf2/NRF1 transcription pathway. Article Snippet: PURPOSE.. The flavonoids have potent antioxidant and free-radical scavenging properties and are beneficial in the prevention and treatment of ocular diseases including glaucoma.. The authors have previously reported that antiglaucoma agents could transcriptionally activate the antioxidant protein peroxiredoxin (PRDX)2. Membrane:Article Title: Isoquinolinequinone N-oxides with diverging mechanisms of action induce collateral sensitivity against multidrug resistant cancer cells. Article Snippet: Multidrug resistance (MDR) is a major challenge in cancer research.. Collateral sensitizers, compounds that exploit the enhanced defense mechanisms of MDR cells as weaknesses, are a proposed strategy to overcome MDR.. Our previous work reported the synthesis of two novel Isoquinolinequinone (IQQ) N-oxides that induce collateral sensitivity in MDR ABCB1-overexpressing non-small cell lung cancer (NSCLC) and colorectal cancer cells. Incubation:Article Title: Isoquinolinequinone N-oxides with diverging mechanisms of action induce collateral sensitivity against multidrug resistant cancer cells. Article Snippet: Multidrug resistance (MDR) is a major challenge in cancer research.. Collateral sensitizers, compounds that exploit the enhanced defense mechanisms of MDR cells as weaknesses, are a proposed strategy to overcome MDR.. Our previous work reported the synthesis of two novel Isoquinolinequinone (IQQ) N-oxides that induce collateral sensitivity in MDR ABCB1-overexpressing non-small cell lung cancer (NSCLC) and colorectal cancer cells. |

